Qualified Person Release
Product Description
Symbiosis Pharmaceutical Services LTD
-
GB -
2015On CPHI since
-
2Certificates
-
100 - 249Employees
Company types
Primary activities
Categories
Symbiosis Pharmaceutical Services LTD
-
GB
-
2015On CPHI since
-
2Certificates
-
100 - 249Employees
Company types
Primary activities
More Products from Symbiosis Pharmaceutical Services LTD (4)
-
Product Sterile Fill Finish
Our facility was purpose-built to meet increasing market demand for shorter sterile drug product development timelines, while consistently maintaining regulatory compliance.
Today, we reliably support our customers with the aseptic filling and lyophilization of conventional, biologic a... -
Product Labelling & Packaging
We offer an efficient clinical labelling and packaging service, which allows us to manage the supply chain logistics of your project and ensure it is delivered to your chosen location. Our goal is to provide a fast and efficient service at all times.
Once your drug product has been m... -
Product Storage
To assure the quality of your medicinal product and support stability storage testing throughout your drug development programme Symbiosis offers facilities for controlled temperature and humidity storage. Operating to GMP and licensed by the MHRA we adhere to industry guidelines for recording storage temp... -
Product Analytical Testing
Coordinating in-process and finished product testing with the completion of batch documentation, we can deliver your drug product within just six weeks of the date of manufacture.
Symbiosis Pharmaceutical Services can manage all of your analytical and microbiologial testing requirements by utili...
Symbiosis Pharmaceutical Services LTD resources (4)
-
News Symbiosis announces acquisition of new facility and investment in automated commercial scale GMP sterile manufacturing.
Symbiosis Pharmaceutical Services Ltd. announced the purchase of new premises in Stirling, Scotland, UK. The new facility and service extension project, supported by a grant from Scottish Enterprise totalling £4.3m ($5.5m), will be implemented over a three-year period as part of a wider £26m ($34.2m) financial commitment by Symbiosis to drive the growth of the company. The growth strategy includes the addition of automated sterile manufacturing production line capabilities to extend the commercial fill/finish services that Symbiosis offers its clients. -
Brochure Aseptic Manufacturing Specialists – Brochure
Our purpose-built MHRA-licenced manufacturing facility has delivered over 1000 projects for clinical and small-scale commercial products. Our seasoned experts can help guide you through your next manufacturing project. The fundamental aim at Symbiosis is to meet your most demanding timelines by offering access to manufacturing slots within weeks, not months, and ensuring that your critical project is delivered on time, to the highest quality standard. -
News Symbiosis confirms commitment to growth strategy with key appointment
The CMO's new Chief Operating Officer will continue the company's operational response to COVID-19. -
News 'Niche' CMO invests in UK facility to expand viral vector sterile manufacturing
CMO's customer base has grown by more than 25% in 2019 alone, and investment and demand for services is estimated to increase output by another 25-30% in 2020.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance